Fox Run Management, L.L.C. Evolus, Inc. Transaction History
Fox Run Management, L.L.C.
- $588 Million
- Q3 2025
A detailed history of Fox Run Management, L.L.C. transactions in Evolus, Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 27,205 shares of EOLS stock, worth $196,420. This represents 0.03% of its overall portfolio holdings.
Number of Shares
27,205Holding current value
$196,420% of portfolio
0.03%Shares
5 transactions
Others Institutions Holding EOLS
# of Institutions
171Shares Held
50.5MCall Options Held
175KPut Options Held
539K-
Nantahala Capital Management, LLC New Canaan, CT5.73MShares$41.3 Million1.43% of portfolio
-
Tang Capital Management LLC San Diego, CA5.49MShares$39.6 Million1.53% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$28.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$24.8 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA2.63MShares$19 Million0.68% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $405M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...